Page last updated: 2024-08-17

triamcinolone acetonide and Paraproteinemias

triamcinolone acetonide has been researched along with Paraproteinemias in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ganne, P; Krishnappa, NC	1

Other Studies

1 other study(ies) available for triamcinolone acetonide and Paraproteinemias

Article	Year
Paraproteinemic Maculopathy in a 63-Year-Old Man. JAMA ophthalmology, 2018, 08-01, Volume: 136, Issue:8 Topics: Angiogenesis Inhibitors; Bevacizumab; Blood Protein Electrophoresis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Retinal Diseases; Stroke; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vision Disorders; Visual Acuity	2018

Article

Year

Paraproteinemic Maculopathy in a 63-Year-Old Man.

JAMA ophthalmology, 2018, 08-01, Volume: 136, Issue:8

Topics: Angiogenesis Inhibitors; Bevacizumab; Blood Protein Electrophoresis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Retinal Diseases; Stroke; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vision Disorders; Visual Acuity

2018